価格表

在庫・価格 : 2024年05月18日 22時00分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-p73, Mouse-Mono(5B429)
NBP2-24737SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥36,000
(未発注)
追加

在庫・価格 : 2024年05月18日 22時00分 現在

Anti-p73, Mouse-Mono(5B429)

  • 商品コード:NBP2-24737SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥36,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Brahimi-Horn MC et al. Local mitochondrial-endolysosomal microfusion cleaves voltage-dependent anion channel 1 to promote survival in hypoxia. Mol. Cell. Biol. 2015 May;35(9):1491-505
Brahimi-Horn MC et al
2015/01/01
Species: Human, Applications: WB PubMed
2 Sayan AE et al. New antibodies recognizing p73: comparison with commercial antibodies. Biochem. Biophys. Res. Commun. 2005 Apr;330(1):186-93
Sayan AE et al
2005/01/01
Species: Human, Applications: IP PubMed
3 Mor I et al. Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility. J. Cell. Mol. Med. 2008 Apr;12(2):479-95
Mor I et al
2008/01/01
Species: Mouse, Applications: WB PubMed
4 Lunghi P et al. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood 2008 Sep;112(6):2450-62
Lunghi P et al
2008/01/01
Species: Human, Applications: WB PubMed
5 Kurihara A et al. Ser46 phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53-dependent apoptosis. Genes Cells 2007 Jul;12(7):853-61
Kurihara A et al
2007/01/01
Applications: WB PubMed
6 Thottassery JV et al. c-Abl-independent p73 stabilization during gemcitabine- or 4"-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. Mol. Cancer Ther. 2006 Feb;5(2):400-10
Thottassery JV et al
2006/01/01
Species: Human, Applications: WB PubMed
7 Chowdhury P et al. Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. Nat Commun 2014;5:5476
Chowdhury P et al
2014/01/01
Species: Human, Applications: IP, WB PubMed
8 Dom鱈nguez G et al. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1. J. Clin. Oncol. 2006 Feb;24(5):805-15
Dom鱈nguez G et al
2006/01/01
Species: Human, Applications: IHC-Fr PubMed
9 Cancino GI et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer"s beta-amyloid deposits. Brain 2008 Sep;131(Pt 9):2425-42
Cancino GI et al
2008/01/01
Species: Rat, Applications: WB PubMed
10 Marqu辿s-Garc鱈a F et al. p73 plays a role in erythroid differentiation through GATA1 induction. J. Biol. Chem. 2009 Aug;284(32):21139-56
Marqu辿s-Garc鱈a F et al
2009/01/01
Applications: ChIP PubMed
11 El Machhour F et al. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J. Am. Soc. Nephrol. 2014 Nov;
El Machhour F et al
2014/01/01
Species: Human, Applications: IP PubMed
12 Frasca F et al. p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res. 2003 Sep;63(18):5829-37
Frasca F et al
2003/01/01
Species: Human, Applications: WB, IF/ICC PubMed
13 Tomasini R et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc. Natl. Acad. Sci. U.S.A. 2009 Jan;106(3):797-802
Tomasini R et al
2009/01/01
Species: Human, Applications: WB PubMed
14 Marinovic-Terzic I et al. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(37):13993-8
Marinovic-Terzic I et al
2008/01/01
Applications: WB PubMed
15 Alvarez AR et al. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease. FASEB J. 2008 Oct;22(10):3617-27
Alvarez AR et al
2008/01/01
Species: Mouse, Applications: IF/ICC PubMed
16 Ma Y et al. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol. Cancer Ther. 2008 Sep;7(9):3047-55
Ma Y et al
2008/01/01
Species: Mouse, Applications: WB PubMed
17 Li LS et al. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. J. Biol. Chem. 2008 Aug;283(31):21394-403
Li LS et al
2008/01/01
Species: Human, Applications: WB PubMed
18 Santag S et al. Recruitment of the tumour suppressor protein p73 by Kaposi"s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells. Oncogene 2013 Aug;32(32):3676-85
Santag S et al
2013/01/01
Applications: PubMed
19 Shimodaira H et al. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. U.S.A. 2003 Mar;100(5):2420-5
Shimodaira H et al
2003/01/01
Applications: WB PubMed
20 Lu H et al. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Neoplasia 2014 Oct;16(10):789-800
Lu H et al
2014/01/01
Species: Human, Applications: WB PubMed
21 Alonso R et al. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Blood 2009 Aug;114(8):1563-75
Alonso R et al
2009/01/01
Applications: PubMed
22 Liu K et al. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer. Mol. Cell. Biol. 2009 May;29(10):2673-93
Liu K et al
2009/01/01
Species: Human, Applications: WB PubMed
23 Brune M et al. Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation. Oncogene 2013 Mar;32(11):1460-8
Brune M et al
2013/01/01
Applications: PubMed
24 Hu X et al. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells. Cancer Chemother. Pharmacol. 2012 May;69(5):1205-12
Hu X et al
2012/01/01
Applications: PubMed
25 Cui R et al. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription. J. Biol. Chem. 2005 Nov;280(47):39152-60
Cui R et al
2005/01/01
Applications: PubMed
26 Arfaoui AT et al. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients. Virchows Arch. 2010 Sep;457(3):359-68
Arfaoui AT et al
2010/01/01
Applications: PubMed
27 Tebbi A et al. TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis. J. Biol. Chem. 2011 Mar;286(10):7873-84
Tebbi A et al
2011/01/01
Applications: PubMed
28 Venkatanarayan A et al. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 2014 Nov;
Venkatanarayan A et al
2014/01/01
Species: Mouse, Applications: WB PubMed
29 Wierda WG et al. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154. Leukemia 2010 Nov;24(11):1893-900
Wierda WG et al
2010/01/01
Applications: PubMed
30 Tonino SH et al. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. Oncogene 2011 Feb;30(6):701-13
Tonino SH et al
2011/01/01
PubMed
31 Limesand KH et al. MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells. Mol. Cell. Biol. 2006 Dec;26(23):8840-56
Limesand KH et al
2006/01/01
PubMed
32 Agostini M et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc. Natl. Acad. Sci. U.S.A. 2011 Dec;108(52):21099-104
Agostini M et al
2011/01/01
PubMed
33 Ma Y et al. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer 2010 Jul;116(13):3294-303
Ma Y et al
2010/01/01
PubMed
34 Malatesta M et al. The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. Oncogene 2012 Oct;
Malatesta M et al
2012/01/01
PubMed
35 Zorić A et al. Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis. Carcinogenesis 2013 Mar;34(3):522-9
Zorić A et al
2013/01/01
PubMed
36 Vella V et al. Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function. J. Biol. Chem. 2003 Jul;278(27):25151-7
Vella V et al
2003/01/01
PubMed
37 Bernassola F et al. Ubiquitin-dependent degradation of p73 is inhibited by PML. J. Exp. Med. 2004 Jun;199(11):1545-57
Bernassola F et al
2004/01/01
PubMed
38 Rosenbluth JM et al. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell Cycle 2009 Nov;8(22):3702-6
Rosenbluth JM et al
2009/01/01
PubMed
39 Bozzetti C et al. p73 and p53 pathway in human breast cancers. J. Clin. Oncol. 2007 Apr;25(11):1451-3; author reply 1453-4
Bozzetti C et al
2007/01/01
PubMed
  • No.: 1
  • 文献情報:
    Brahimi-Horn MC et al. Local mitochondrial-endolysosomal microfusion cleaves voltage-dependent anion channel 1 to promote survival in hypoxia. Mol. Cell. Biol. 2015 May;35(9):1491-505
    Brahimi-Horn MC et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sayan AE et al. New antibodies recognizing p73: comparison with commercial antibodies. Biochem. Biophys. Res. Commun. 2005 Apr;330(1):186-93
    Sayan AE et al
    2005/01/01
  • 備考:
    Species: Human, Applications: IP
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Mor I et al. Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility. J. Cell. Mol. Med. 2008 Apr;12(2):479-95
    Mor I et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Lunghi P et al. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood 2008 Sep;112(6):2450-62
    Lunghi P et al
    2008/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kurihara A et al. Ser46 phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53-dependent apoptosis. Genes Cells 2007 Jul;12(7):853-61
    Kurihara A et al
    2007/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Thottassery JV et al. c-Abl-independent p73 stabilization during gemcitabine- or 4"-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cells. Mol. Cancer Ther. 2006 Feb;5(2):400-10
    Thottassery JV et al
    2006/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chowdhury P et al. Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. Nat Commun 2014;5:5476
    Chowdhury P et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IP, WB
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Dom鱈nguez G et al. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1. J. Clin. Oncol. 2006 Feb;24(5):805-15
    Dom鱈nguez G et al
    2006/01/01
  • 備考:
    Species: Human, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cancino GI et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer"s beta-amyloid deposits. Brain 2008 Sep;131(Pt 9):2425-42
    Cancino GI et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Marqu辿s-Garc鱈a F et al. p73 plays a role in erythroid differentiation through GATA1 induction. J. Biol. Chem. 2009 Aug;284(32):21139-56
    Marqu辿s-Garc鱈a F et al
    2009/01/01
  • 備考:
    Applications: ChIP
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    El Machhour F et al. Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease. J. Am. Soc. Nephrol. 2014 Nov;
    El Machhour F et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IP
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Frasca F et al. p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res. 2003 Sep;63(18):5829-37
    Frasca F et al
    2003/01/01
  • 備考:
    Species: Human, Applications: WB, IF/ICC
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Tomasini R et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc. Natl. Acad. Sci. U.S.A. 2009 Jan;106(3):797-802
    Tomasini R et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Marinovic-Terzic I et al. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(37):13993-8
    Marinovic-Terzic I et al
    2008/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Alvarez AR et al. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease. FASEB J. 2008 Oct;22(10):3617-27
    Alvarez AR et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: IF/ICC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Ma Y et al. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol. Cancer Ther. 2008 Sep;7(9):3047-55
    Ma Y et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Li LS et al. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. J. Biol. Chem. 2008 Aug;283(31):21394-403
    Li LS et al
    2008/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Santag S et al. Recruitment of the tumour suppressor protein p73 by Kaposi"s Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells. Oncogene 2013 Aug;32(32):3676-85
    Santag S et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Shimodaira H et al. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. U.S.A. 2003 Mar;100(5):2420-5
    Shimodaira H et al
    2003/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Lu H et al. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. Neoplasia 2014 Oct;16(10):789-800
    Lu H et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Alonso R et al. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Blood 2009 Aug;114(8):1563-75
    Alonso R et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Liu K et al. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer. Mol. Cell. Biol. 2009 May;29(10):2673-93
    Liu K et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Brune M et al. Depletion of the receptor for advanced glycation end products (RAGE) sensitizes towards apoptosis via p53 and p73 posttranslational regulation. Oncogene 2013 Mar;32(11):1460-8
    Brune M et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Hu X et al. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells. Cancer Chemother. Pharmacol. 2012 May;69(5):1205-12
    Hu X et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Cui R et al. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription. J. Biol. Chem. 2005 Nov;280(47):39152-60
    Cui R et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Arfaoui AT et al. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients. Virchows Arch. 2010 Sep;457(3):359-68
    Arfaoui AT et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Tebbi A et al. TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis. J. Biol. Chem. 2011 Mar;286(10):7873-84
    Tebbi A et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Venkatanarayan A et al. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 2014 Nov;
    Venkatanarayan A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Wierda WG et al. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154. Leukemia 2010 Nov;24(11):1893-900
    Wierda WG et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Tonino SH et al. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. Oncogene 2011 Feb;30(6):701-13
    Tonino SH et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Limesand KH et al. MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells. Mol. Cell. Biol. 2006 Dec;26(23):8840-56
    Limesand KH et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Agostini M et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc. Natl. Acad. Sci. U.S.A. 2011 Dec;108(52):21099-104
    Agostini M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Ma Y et al. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer 2010 Jul;116(13):3294-303
    Ma Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Malatesta M et al. The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. Oncogene 2012 Oct;
    Malatesta M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Zorić A et al. Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis. Carcinogenesis 2013 Mar;34(3):522-9
    Zorić A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Vella V et al. Exclusion of c-Abl from the nucleus restrains the p73 tumor suppression function. J. Biol. Chem. 2003 Jul;278(27):25151-7
    Vella V et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Bernassola F et al. Ubiquitin-dependent degradation of p73 is inhibited by PML. J. Exp. Med. 2004 Jun;199(11):1545-57
    Bernassola F et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Rosenbluth JM et al. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell Cycle 2009 Nov;8(22):3702-6
    Rosenbluth JM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Bozzetti C et al. p73 and p53 pathway in human breast cancers. J. Clin. Oncol. 2007 Apr;25(11):1451-3; author reply 1453-4
    Bozzetti C et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed